Presented by
Management Forum
Making Financial Sense of GMP (Good Manufacturing Practice): Quality Risk Management (QRM) Training Course
In this talk, explore how the Quality Risk Management (QRM) impacts the financials of an organisation and how it can enhance an organisation's financial strength.
7 November 2025
+ 17 April 2026 »
from £99
- Format: Live online
- CPD: 1.5 hours for your records
- Certificate of completion
Part of Making Financial Sense of GMP series:
Are you aware of how the GxP requirements impact the financials of an organisation? This exciting series provides a concise overview of some key elements of GxP such as Pharmaceutical Quality System, Validation Master Plan, Risk Management and Change Management. Participants will learn about how these elements impact the gross profit, operational costs and net profit.
Course overview
Quality Risk Management (QRM) is outlined in ICH Q9 guideline. The importance of quality systems has been recognised in the pharmaceutical industry and it is evident that quality risk management is a valuable component of an effective quality system.
The QRM includes the following elements:
- Risk Assessment
- Risk Control
- Risk Review
- Risk Communication
Working with QRM has cost implications. When used effectively, QRM can be used for cost vs benefit analysis. What are the financial risks involved if an organisation does not implement an effective Vendor Approval System or a Validation Master Plan? Is QRM and expectation or a must for an organisation?
This course is part of our GxP training (Good x Practice) course collection, which features a variety of topic areas to ensure you comply with the most recent quality guidelines.
Benefits of attending
Attending this session will help deepen your knowledge and support your understanding on how the Quality Risk Management (QRM) benefits an organisation's financial performance.
The benefits of attending this session include:
- Learn about the impact of QRM on the gross profit, operational costs and net profit
- Explore how QRM can support efforts to reduce costs and improve profits
- Discuss QRM elements that contribute to cost reduction
- Understand how financial decisions don't have to compromise QRM
- Consider what would happen if QRM was not a regulatory expectation
Who should attend?
This session is designed for senior life science professionals involved with Quality Risk Management (QRM) either directly or indirectly.
The stakeholders are typically from executive and management roles responsible for and involved in decision making and striving to balance financial goals with compliance and quality requirements.
Other interested stakeholders not directly involved with compliance or quality include:
- Chief Operating Officers
- Chief Financial Officers
- Finance and costing analysts
Jitan Bhudia
Venn Helix
Jitan Bhudia is a highly accomplished Pharmaceutical Consultant with extensive expertise in Good Manufacturing Practice (GMP), Good Distribution Practice (GDP), and regulatory compliance within the pharmaceutical industry. With a career spanning over two decades, Jitan has a proven track record of leading business operations, ensuring regulatory compliance, and driving commercial success in pharmaceutical manufacturing and distribution.
As the co-founder of jarmatrixpharma.com, a site dedicated to help organisations “manage knowledge”, Jitan has provided specialized consulting and tailored training solutions for pharmaceutical manufacturing. He has designed and implemented Quality and Document Management Systems, supported regulatory audits, and worked closely with industry stakeholders to ensure compliance with stringent pharmaceutical regulations. His ability to develop cost-effective compliance solutions and deliver expert training on quality management strategies has positioned him as a trusted advisor in the field.
Previously, Jitan served as the Owner, Director, and Head of Production at Percuro Medica Limited, where he played a pivotal role in establishing and expanding the company. Under his leadership, the company gained essential licenses from the MHRA and the Home Office for the manufacture and distribution of controlled drugs. His expertise in facility design, validation, and risk management helped secure major contracts with pharmaceutical companies.
With his deep industry knowledge, regulatory expertise, and business acumen, Jitan continues to support pharmaceutical organizations in navigating complex compliance landscapes, optimizing quality systems, and achieving operational excellence.
NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:
- 30% off the 2nd delegate*
- 40% off the 3rd delegate*
- 50% off the 4th delegate*
Please contact us for pricing if you are interested in booking 5 or more delegates
7 November 2025
Live online
12:00-13:30 UK (London) (UTC+00)
13:00-14:30 Paris (UTC+01)
07:00-08:30 New York (UTC-05)
Course code 15640
- GBP 99 124
- EUR 139 174
- USD 160 199
Until 03 Oct
- 90 minutes of live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
17 April 2026
Live online
12:00-13:30 UK (London) (UTC+01)
13:00-14:30 Paris (UTC+02)
07:00-08:30 New York (UTC-04)
Course code 15641
- GBP 99 124
- EUR 139 174
- USD 160 199
Until 13 Mar
- 90 minutes of live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.
United Kingdom
- University of Sheffield
